Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Apogee Therapeutics, Inc. | Chief Financial Officer | Common Stock | 201K | $9.69M | $48.26 | Aug 23, 2024 | Direct |
Adagio Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 175K | Jan 30, 2022 | Direct | ||
Apogee Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 125K | Dec 9, 2024 | Direct | ||
Sesen Bio, Inc. | Director | Stock Option | 92.5K | May 3, 2021 | Direct | ||
CARGO Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 39.4K | Jun 4, 2024 | Direct | ||
Akero Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 26K | Jun 8, 2024 | Direct | ||
IVERIC bio, Inc. | Director | Common Stock | 0 | $39.45 | Jul 11, 2023 | Direct | |
IVERIC bio, Inc. | Director | Restricted Stock Units | 0 | Jul 11, 2023 | Direct | ||
IVERIC bio, Inc. | Director | Stock Option (Right to Buy) | 0 | $10.03 | Jul 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APGE | Apogee Therapeutics, Inc. | Dec 9, 2024 | 1 | $0 | 4 | Dec 11, 2024 | Chief Financial Officer |
APGE | Apogee Therapeutics, Inc. | Aug 23, 2024 | 1 | -$290K | 4 | Aug 23, 2024 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Jun 8, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
CRGX | CARGO Therapeutics, Inc. | Jun 4, 2024 | 2 | $0 | 4 | Jun 6, 2024 | Director |
CRGX | CARGO Therapeutics, Inc. | Jun 3, 2024 | 0 | $0 | 3 | Jun 6, 2024 | Director |
APGE | Apogee Therapeutics, Inc. | Dec 18, 2023 | 1 | $0 | 4 | Dec 20, 2023 | Chief Financial Officer |
APGE | Apogee Therapeutics, Inc. | Jul 13, 2023 | 0 | $0 | 3/A | Jul 17, 2023 | Chief Financial Officer |
ISEE | IVERIC bio, Inc. | Jul 11, 2023 | 8 | $0 | 4 | Jul 13, 2023 | Director |
AKRO | Akero Therapeutics, Inc. | Jun 23, 2023 | 1 | $0 | 4 | Jun 27, 2023 | Director |
AKRO | Akero Therapeutics, Inc. | Jun 16, 2023 | 4 | -$1.89M | 4 | Jun 21, 2023 | Director |
ISEE | IVERIC bio, Inc. | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
ISEE | IVERIC bio, Inc. | May 11, 2023 | 2 | $0 | 4 | May 15, 2023 | Director |
AKRO | Akero Therapeutics, Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
ISEE | IVERIC bio, Inc. | May 11, 2022 | 4 | $0 | 4 | May 13, 2022 | Director |
IVVD | Adagio Therapeutics, Inc. | Jan 30, 2022 | 1 | $0 | 4 | Feb 1, 2022 | Chief Financial Officer |
IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 0 | $0 | 3 | Aug 5, 2021 | Chief Financial Officer |
AKRO | Akero Therapeutics, Inc. | Jun 1, 2021 | 1 | $0 | 4 | Jun 3, 2021 | Director |
ISEE | IVERIC bio, Inc. | May 19, 2021 | 2 | $0 | 4 | May 20, 2021 | Director |
CARM | Sesen Bio, Inc. | May 3, 2021 | 1 | $0 | 4 | May 10, 2021 | Director |